Bridgeway Capital Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History
Bought
Maintained
Sold
Bridgeway Capital Management's BTX.WS Position: Q3 2018 in Review
Bridgeway Capital Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 16,348 shares — an estimated $1K sold.
Bridgeway Capital Management first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $33K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.
- Bridgeway Capital Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
- Bridgeway Capital Management sold 16,348 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018, an estimated $1K.
- Bridgeway Capital Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
- Bridgeway Capital Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $33K in Q1 2015.
- 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.
Based on Bridgeway Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.